APOL1 and nonpapillary renal cell carcinoma: To further study the effect of APOL1 on lipid metabolism in ccRCC, we stably inhibited APOL1 in three VHL(−/−) ccRCC cell lines (786-O, A498 and OS-RC-2) with lenti-viruses carrying shRNA (Fig. 2A and B).